Golden Bazaar company screen
ONCSM
ONCOSEM ONKOLOJIK SISTEMLER SANAYI VE TICARET A.S.
Latest period read
Golden Bazaar2026/3
Income statement239.0M TRYRevenue
Margin read130.3M TRYGross profit
Operating strength53.6M TRYOperating profit
Cash-profit proxy70.6M TRYEBITDA
Debt load1.6B TRYNet debt
Balance-sheet risk345.3M TRYFinancial debt
Shareable report
Share image
One image for social sharing. If statement rows are missing, it only shows profile and market status.
GOLDEN BAZAARBIST Company Financial Report
ONCSM
ONCOSEM ONKOLOJIK SISTEMLER SANAYI VE TICARET A.S.
Total assets792.6M TRY
Equity447.3M TRY
F/K10,440.71
PD/DD13.88
Net profit5.9B TRY
Company information
Legal nameONCOSEM ONKOLOJIK SISTEMLER SANAYI VE TICARET A.S.
SectorİMALAT
MarketBIST
CityANKARA
Foundation / registry dateNot listed in the registry record
IPO dateNot listed in the official record
First trading dateNot listed in the official record
Websitewww.oncosem.com
Return intelligence
Processed date: 02 Jun 20261W TRY-17.69%
1M TRY+7.50%
1Y TRY+2.54%
SAME SECTOR COMPARISON
Market date: 21 Jun 2026Same sector peers
Comparison basis: Accounting group / i̇malatPeer universe: 10With market data: 10
Swipe horizontally to see the full peer table.
Metric
ONCSMARMGDASUZUASGYOATAKPAGROTARSANAGYOAKYHOATAGYAvg
Market cap
6.2B TRY
44.0B TRY
15.2B TRY
7.9B TRY
7.5B TRY
6.7B TRY
5.9B TRY
2.3B TRY
630.4M TRY
591.4M TRY
9.7B TRY
F/K
104.41
7.62
37.30
1.40
-7.18
-4.34
1.12
-2.27
-2.87
-5.06
9.18
PD/DD
13.90
6.20
1.00
0.30
1.10
0.80
0.50
0.40
1.00
0.80
2.60
EV/EBITDA
25
30
18
—
15
160
5
17
17
139
47
ROE
—
+0.01%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Period ratio matrix
Margin, liquidity, and profitability heatmap
Green marks stronger readings; red marks weak or riskier readings. A full historical valuation multiple matrix needs market cap and enterprise value for each period.
Oran Matrisi (Is\u0131 Haritas\u0131)
Ye\u015fil=g\u00fc\u00e7l\u00fc, K\u0131rm\u0131z\u0131=zay\u0131f \u2022 Fareyle \u00fczerine gel
| Oran | 2024/3 | 2024/6 | 2024/9 | 2024/12 | 2025/3 | 2025/6 | 2025/9 | 2025/12 | 2026/3 | 2026/6 | 2026/9 | 2026/12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Brüt Marj % | +13.39% | +33.36% | +38.68% | +36.99% | +43.39% | +33.55% | +37.17% | +45.11% | +54.53% | — | — | — |
| Faaliyet Marjı % | — | — | — | — | — | — | +11.76% | +19.74% | +22.43% | — | — | — |
| Net Marj % | — | — | — | — | — | — | — | — | — | — | — | — |
| ROE % | — | — | — | — | — | — | — | — | — | — | — | — |
| ROA % | — | — | — | — | — | — | — | — | — | — | — | — |
| Cari Oran | — | — | — | — | — | — | 2.50 | 2.61 | 2.25 | — | — | — |
| Kaldıraç % | — | — | — | — | — | — | — | — | — | — | — | — |
| F/K (P/E) | — | — | — | — | 7115.79 | — | 2.75 | 1.39 | 11794.62 | — | — | — |
| PD/DD (P/B) | — | — | — | — | — | — | — | — | — | — | — | — |
| FD/FAVOK | — | — | — | 0.71 | — | 0.86 | 1.14 | 0.29 | 0.99 | — | — | — |
Balance periods
All Balance Sheets
Current assets, non-current assets, liabilities, and equity are shown together by reporting period.
| Line item | 2026/3 | 2025/12 | 2025/9 | TTM |
|---|---|---|---|---|
| Current assets | 523.9M | 404.1M | 335.1M | — |
| Non-current assets | 268.7M | 220.1M | 210.4M | — |
| Total assets | 792.6M | 624.2M | 545.5M | — |
| Current liabilities | 233.0M | 154.8M | 134.0M | — |
| Non-current liabilities | 112.3M | 62.3M | 44.8M | — |
| Total liabilities | 345.3M | 217.2M | 178.8M | — |
| Equity | 447.3M | 407.0M | 366.7M | — |
| Net debt | 1.6B | 839.8M | 699.6M | 1.9B |
Cash flow periods
Cash Flow Summary
Operating, investing, and financing cash flows are shown by reporting period. Free cash flow is shown when available.
| Line item | 2026/3 | 2025/12 | 2025/9 | TTM |
|---|---|---|---|---|
| Operating cash flow | -1.3M | 69.4M | 41.0M | 151.4M |
| Investing cash flow | -31.1M | -65.7M | -49.0M | — |
| Financing cash flow | 43.5M | -3.7M | -11.5M | — |
Income statement
Revenue, margin, operating profit, and net profit trend.
4 lines10 periods shown
| Financial line | 2026/3 | 2025/12 | 2025/9 | 2025/6 | 2025/3 | 2024/12 | 2024/9 | 2024/6 | 2024/3 | TTM | Last period change |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 239.0M | 780.3M | 523.4M | 341.9M | 219.5M | 490.2M | 370.5M | 213.8M | 96.7M | 728.6M | -69.37% |
| Gross Profit | 130.3M | 351.9M | 194.5M | 114.7M | 95.2M | 181.3M | 143.3M | 71.3M | 13.0M | 354.9M | -62.97% |
| Administrative Expenses | -63.5M | -151.1M | -112.8M | -71.9M | -47.9M | -150.9M | -115.7M | -72.8M | -33.6M | — | +58.01% |
| Marketing Expenses | -10.4M | -26.7M | -16.2M | -9.7M | -5.5M | -21.4M | -15.8M | -11.0M | -6.2M | — | +61.07% |
Cash flow
Cash movements from operating, investing, and financing activities.
1 lines4 periods shown
| Financial line | 2026/3 | 2025/12 | 2025/9 | TTM | Last period change |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.3M | 69.4M | 41.0M | 42.4M | -101.94% |
Financial trends
2024/12119.7M TL
2025/3219.5M TL
2025/6122.4M TL
2025/9181.5M TL
2025/12256.9M TL
2026/3239.0M TL